NCT06925581View on ClinicalTrials.gov

A Trial of HRS-6768 in Patients With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

84

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

HRS-6768

HRS-6768

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY